GLP-1 receptor agonists market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). The increasing advancement in drug development along with the presence of a strong product pipeline is anticipated to drive the growth of the global market. GLP-1 receptor agonists are a category of antidiabetic agents that performs functioning of the glucagon-like peptide. GLP-1 is a natural incretin compound that influences the body functioning once they get released from the gut during digestion. The growing prevalence of obesity and the geriatric population that leads to diabetes are some other factors anticipated to drive the growth of the global market.

(Get 15% Discount on Buying this Report)Get Report Sample Copy @ https://www.omrglobal.com/request-sample/glucagon-like-peptide-1-glp-1-receptor-agonists-market
The GLP-1 receptor agonists market is segmented on the basis of drug type. Based on drug type, the market is segmented into Exenatide (Bydureon, Byetta), LiraglutidE (Victoza), Lixisenatide (Lyxumia), and Dulaglutide (Trulicity). Dulaglutide is anticipated to hold major market share based on drug type during the forecast period. Dulaglutide (Trulicity) is a medication prepared by Eli Lily and Company. It is a prescribed medication for adults with type 2 diabetes to improve blood sugar (glucose). In addition, this medication is used to reduce the risk of major cardiovascular disorders such as heart attack. The increasing number of prescriptions for trulicity owing to its offered benefits is a key factor contributing to the growth of this market segment.
A Full Report of GlobalGLP-1 receptor agonistsMarketis Available at: https://www.omrglobal.com/industry-reports/glucagon-like-peptide-1-glp-1-receptor-agonists-market
Market Segmentation

Global GLP-1 receptor agonists Market by Drug Type

 Exenatide
 Liraglutide
 Lixisenatide
 Dulaglutide

Company Profiles

 AstraZeneca PLC
 Bristol Mayer Squibb, Co.
 Eli Lilly & Company
 Merck & Co., Inc.
 Novo Nordisk A/S
 Sanofi SA

Global Market– Segmentation by Region
North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America


For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report-customization/glucagon-like-peptide-1-glp-1-receptor-agonists-market
Reasons to Buying From us –
• We cover more than 15 major industries, further segmented into more than 90 sectors.
• More than 120 countries are for analysis.
• Over 100+ paid data sources mined for investigation.
• Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404